Medicare’s drug pricing negotiations — the first of their kind in the United States, passed under President Joe Biden — face ...

Polls provide a useful window into understanding how Americans view their own weight and the recent availability of drugs ...

Novo Nordisk faces scrutiny over UK pharmacy sponsorships tied to weight-loss drugs, with critics citing conflicts of interest and regulatory breaches.

Shaelyn Weaver, after struggling with weight issues due to PCOS and pre-diabetes, embarked on a significant weight loss ...

New tests may show how much value a particular obese patient will get for a GLP-1 agonist prescription dollar.

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

Ozempic and Wegovy, prescription weight loss ... barred by an old federal law from paying for weight-loss drugs. But last November Biden proposed new rules to allow Medicare and Medicaid to ...

A systematic review of randomized controlled trials (RCTs) assessed the efficacy and safety of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and co-agonists for obesity in adults without ...

As the new year sparks a wave of weight loss resolutions and millions turn to weight loss medications, rising costs and the ...

New Year’s is receding fast in the rearview mirror. And for many of us, our sincere resolutions about losing weight and ...

In January 2023, the world was abuzz with stories of a revolutionary weight-loss drug – a simple, self-administered injection ...

Long-Term Benefits of Weight-Loss Surgery in Young People ... Oct. 30, 2024 — A new study, using responses from the U.S. National Survey on Drug Use and Health, has found that about 6 percent ...